[1] |
LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong.
One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212.
|
[2] |
MENG Kangkang, LIU Saiyue.
After-marketing safety of coenzyme Q10 for injection
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 795-798.
|
[3] |
CHEN Cheng, DENG Li, LIU Songqing, DU Qian, XI Xin.
Analysis of reports of allergic shock in Chongqing between 2015 and 2020
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 460-464.
|
[4] |
YAO Yu, LI Yuanyuan, WEI Xu, XIE Yanming, WANG Zhifei, GAO Minghui.
Influencing factors of suspected allergic reactions related to cervus and cucumis polypeptide for injection in the real world
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 740-743.
|
[5] |
YI Yan, TIAN Jingzhuo, LI Chunying, ZHAO Yong, LIANG Aihua.
Pesudoallergic reactions during post-marketing non-clinical safety reevaluation of traditional Chinese medicine injections
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(2): 185-188.
|
[6] |
LIU Chun, WANG Jucai, HUANG Yuchang, YE Xiaoqing, ZHAO Yingshu, ZHAN Meimei, WANG Chen.
Allergic test of azithromycin for injection in guinea pigs in non-clinical safety evaluation
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(11): 1161-1164.
|
[7] |
PANG Yu, ZHU Lan, WANG Tao, YU Hongli, SHAO Bo, LIU Bo.
Analysis of Risks of Longbishu Preparation
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(9): 869-871.
|
[8] |
XU Xianxing, YANG Jingwen, MIAO Huiqing.
Potential Risks of Salviae Miltiorrhizae and Ligustrazine Injection
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(6): 575-578.
|
[9] |
CONG Duanduan, XUE Wei, LIU Yue, QI Wenyuan, LIU Xiaohui, WANG Juan, LI Kexin, HU Xin.
Management of Safety Information in Prescription Drug Labeling in China, Japan and the United States
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(3): 245-249.
|
[10] |
XU Shungui, LIU Chunguang.
Survey of the Regulation System of OTC Drugs in the United States
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(2): 141-144.
|
[11] |
FU Hong, RONG Youhe.
One Case of Severe Adverse Drug Reactions Induced by rt-PA and Literature Analysis
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(12): 1198-1200.
|
[12] |
QIN Xueying, SUN Linxi, XIE Yanming, LYU Jian, ZHANG Cheng, XIE Yuting, GUO Peng.
Influencing Factors of Suspected Allergic Reactions Caused by Yinzhihuang Granules in the Real World
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(10): 936-939.
|
[13] |
ZHANG Baiyu, XIE Yanming, LIU Huan, SUN Linxi, ZHUANG Yunni.
Influencing Factors of Suspected Allergic Reactions Caused by Ciwujia Injection Based on Prescription Sequence Analysis and Nested Case-control Design
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(10): 956-959.
|
[14] |
ZHAO Shuang, GU Rui, SONG Yanqing, WANG Xiangfeng, MIAO Qiuli.
Information Labeling in Instructions of Anti-tumor Drugs for Intravenous Infusion in a Hospital
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(10): 978-980.
|
[15] |
WENG Lihong, GAO Huan, HU Xue, ZHANG Wenrui.
Infusion Requirements on Labels of 39 Chinese Traditional Medicine Injections
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(7): 437-440.
|